脂质代谢在脑胶质瘤中的研究进展
Research Progress of Lipid Metabolism in Brain Glioma
DOI: 10.12677/acm.2024.14112858, PDF,   
作者: 王 强, 王 飞*：内蒙古医科大学附属医院神经外科，内蒙古 呼和浩特
关键词: 胶质瘤；脂质代谢；胆固醇；脂肪酸；Glioma； Lipid Metabolism； Cholesterol； Aliphatic Acid
摘要: 胶质瘤(Glioma)是指起源于神经胶质细胞的肿瘤，是中枢神经系统最常见的原发性恶性肿瘤，具有复发率高、预后差等特点，目前治疗方案主要以手术辅以放、化疗为主。代谢重编程是肿瘤的标志，作为三种主要物质代谢之一，脂质具有明显的影响。脂质代谢通过调节各种致癌信号途径参与肿瘤的发生、发育、侵袭和转移。为了进一步了解脂质代谢在胶质瘤细胞中所起到的作用，本文就脂质代谢与脑胶质瘤之间的关系及其相关机制作一综述，探讨脂质代谢在其发生发展中的作用和意义。
Abstract: Glioma, a tumor originating from glial cells, is the most common primary malignant tumor in the central nervous system, characterized by high recurrence rate and poor prognosis. Currently, surgery, radiotherapy and chemotherapy are the main treatment options. Metabolic reprogramming is a hallmark of tumors, and as one of the three major substances metabolized, lipids have a clear effect. Lipid metabolism is involved in the occurrence, development, invasion and metastasis of tumors by regulating various carcinogenic signaling pathways. In order to further understand the role of lipid metabolism in glioma cells, this article reviewed the relationship between lipid metabolism and brain glioma and its related mechanisms, and discussed the role and significance of lipid metabolism in its occurrence and development.
文章引用：王强, 王飞. 脂质代谢在脑胶质瘤中的研究进展[J]. 临床医学进展, 2024, 14(11): 147-151. https://doi.org/10.12677/acm.2024.14112858

参考文献

[1] Xun, Y., Yang, H., Kaminska, B. and You, H. (2021) Toll-Like Receptors and Toll-Like Receptor-Targeted Immunotherapy against Glioma. Journal of Hematology & Oncology, 14, Article No. 176. [Google Scholar] [CrossRef] [PubMed]
[2] Lang, F., Liu, Y., Chou, F. and Yang, C. (2021) Genotoxic Therapy and Resistance Mechanism in Gliomas. Pharmacology & Therapeutics, 228, Article ID: 107922. [Google Scholar] [CrossRef] [PubMed]
[3] Oldrini, B., Vaquero-Siguero, N., Mu, Q., Kroon, P., Zhang, Y., Galán-Ganga, M., et al. (2020) MGMT Genomic Rearrangements Contribute to Chemotherapy Resistance in Gliomas. Nature Communications, 11, Article No. 3883. [Google Scholar] [CrossRef] [PubMed]
[4] Hombach-Klonisch, S., Mehrpour, M., Shojaei, S., Harlos, C., Pitz, M., Hamai, A., et al. (2018) Glioblastoma and Chemoresistance to Alkylating Agents: Involvement of Apoptosis, Autophagy, and Unfolded Protein Response. Pharmacology & Therapeutics, 184, 13-41. [Google Scholar] [CrossRef] [PubMed]
[5] Bian, X., Liu, R., Meng, Y., Xing, D., Xu, D. and Lu, Z. (2020) Lipid Metabolism and Cancer. Journal of Experimental Medicine, 218, e20201606. [Google Scholar] [CrossRef] [PubMed]
[6] Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C. and Benitah, S.A. (2022) The Role of Lipids in Cancer Progression and Metastasis. Cell Metabolism, 34, 1675-1699. [Google Scholar] [CrossRef] [PubMed]
[7] Yang, K., Wang, X., Song, C., He, Z., Wang, R., Xu, Y., et al. (2023) The Role of Lipid Metabolic Reprogramming in Tumor Microenvironment. Theranostics, 13, 1774-1808. [Google Scholar] [CrossRef] [PubMed]
[8] Jin, H., Wang, J., Wang, Z., Xi, M., Xia, B., Deng, K., et al. (2023) Lipid Metabolic Reprogramming in Tumor Microenvironment: From Mechanisms to Therapeutics. Journal of Hematology & Oncology, 16, Article No. 103. [Google Scholar] [CrossRef] [PubMed]
[9] Butler, L.M., Perone, Y., Dehairs, J., Lupien, L.E., de Laat, V., Talebi, A., et al. (2020) Lipids and Cancer: Emerging Roles in Pathogenesis, Diagnosis and Therapeutic Intervention. Advanced Drug Delivery Reviews, 159, 245-293. [Google Scholar] [CrossRef] [PubMed]
[10] Kim, D., Song, N. and Yim, H. (2023) Targeting Dysregulated Lipid Metabolism in the Tumor Microenvironment. Archives of Pharmacal Research, 46, 855-881. [Google Scholar] [CrossRef] [PubMed]
[11] Corbet, C. and Feron, O. (2017) Emerging Roles of Lipid Metabolism in Cancer Progression. Current Opinion in Clinical Nutrition & Metabolic Care, 20, 254-260. [Google Scholar] [CrossRef] [PubMed]
[12] Terry, A.R. and Hay, N. (2024) Emerging Targets in Lipid Metabolism for Cancer Therapy. Trends in Pharmacological Sciences, 45, 537-551. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, B., Song, B. and Xu, C. (2020) Cholesterol Metabolism in Cancer: Mechanisms and Therapeutic Opportunities. Nature Metabolism, 2, 132-141. [Google Scholar] [CrossRef] [PubMed]
[14] Betsholtz, C. (2015) Lipid Transport and Human Brain Development. Nature Genetics, 47, 699-701. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, J., Liu, B., Xu, C., Ji, C., Yin, A., Liu, Y., et al. (2023) Cholesterol Homeostasis Confers Glioma Malignancy Triggered by hnRNPA2b1-Dependent Regulation of SREBP2 and LDLR. Neuro-Oncology, 26, 684-700. [Google Scholar] [CrossRef] [PubMed]
[16] Ng, M.Y.W., Charsou, C., Lapao, A., Singh, S., Trachsel-Moncho, L., Schultz, S.W., et al. (2022) The Cholesterol Transport Protein GRAMD1C Regulates Autophagy Initiation and Mitochondrial Bioenergetics. Nature Communications, 13, Article No. 6283. [Google Scholar] [CrossRef] [PubMed]
[17] Takahashi, K., Kimura, G., Endo, Y., Akatsuka, J., Hayashi, T., Toyama, Y., et al. (2019) Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Case Report and Literature Review. Journal of Nippon Medical School, 86, 349-351. [Google Scholar] [CrossRef] [PubMed]
[18] Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Li, J., et al. (2023) Functional Significance of Cholesterol Metabolism in Cancer: From Threat to Treatment. Experimental & Molecular Medicine, 55, 1982-1995. [Google Scholar] [CrossRef] [PubMed]
[19] Saad, E.E., Michel, R. and Borahay, M.A. (2024) Cholesterol and Immune Microenvironment: Path towards Tumorigenesis. Current Nutrition Reports, 13, 557-565. [Google Scholar] [CrossRef] [PubMed]
[20] Lu, J., Chen, S., Bai, X., Liao, M., Qiu, Y., Zheng, L., et al. (2023) Targeting Cholesterol Metabolism in Cancer: From Molecular Mechanisms to Therapeutic Implications. Biochemical Pharmacology, 218, Article ID: 115907. [Google Scholar] [CrossRef] [PubMed]
[21] Ma, Q., Jiang, H., Ma, L., Zhao, G., Xu, Q., Guo, D., et al. (2023) The Moonlighting Function of Glycolytic Enzyme Enolase-1 Promotes Choline Phospholipid Metabolism and Tumor Cell Proliferation. Proceedings of the National Academy of Sciences of the United States of America, 120, e2209435120. [Google Scholar] [CrossRef] [PubMed]
[22] Koch, K., Hartmann, R., Schröter, F., Suwala, A.K., Maciaczyk, D., Krüger, A.C., et al. (2016) Reciprocal Regulation of the Cholinic Phenotype and Epithelial-Mesenchymal Transition in Glioblastoma Cells. Oncotarget, 7, 73414-73431. [Google Scholar] [CrossRef] [PubMed]
[23] Zhu, R., Yang, Y., Shao, F., Wang, J., Gao, Y., He, J., et al. (2022) Choline Kinase α2 Promotes Lipid Droplet Lipolysis in Non-Small-Cell Lung Carcinoma. Frontiers in Oncology, 12, Article 848483. [Google Scholar] [CrossRef] [PubMed]
[24] Li, Z., Tan, Y., Li, X., Quan, J., Bode, A.M., Cao, Y., et al. (2022) DHRS2 Inhibits Cell Growth and Metastasis in Ovarian Cancer by Downregulation of CHKα to Disrupt Choline Metabolism. Cell Death & Disease, 13, Article No. 845. [Google Scholar] [CrossRef] [PubMed]
[25] Miao, Y., Wang, J., Hao, S., Deng, Y., Zhang, Z., Jin, Z., et al. (2023) The Inhibition of Aurora a Kinase Regulates Phospholipid Remodeling by Upregulating LPCAT1 in Glioblastoma. Neoplasma, 70, 260-271. [Google Scholar] [CrossRef] [PubMed]
[26] Saito, R.D.F., Andrade, L.N.D.S., Bustos, S.O. and Chammas, R. (2022) Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk between Cancer Cells and Immune Cells. Frontiers in Immunology, 13, Article 768606. [Google Scholar] [CrossRef] [PubMed]
[27] Philipsen, M.H., Hansson, E., Manaprasertsak, A., Lange, S., Jennische, E., Carén, H., et al. (2023) Distinct Cholesterol Localization in Glioblastoma Multiforme Revealed by Mass Spectrometry Imaging. ACS Chemical Neuroscience, 14, 1602-1609. [Google Scholar] [CrossRef] [PubMed]
[28] Mercurio, L., Cecchetti, S., Ricci, A., Pacella, A., Cigliana, G., Bozzuto, G., et al. (2017) Phosphatidylcholine-Specific Phospholipase C Inhibition Down-Regulates CXCR4 Expression and Interferes with Proliferation, Invasion and Glycolysis in Glioma Cells. PLOS ONE, 12, e0176108. [Google Scholar] [CrossRef] [PubMed]
[29] Kuwata, H. and Hara, S. (2019) Role of Acyl-Coa Synthetase ACSL4 in Arachidonic Acid Metabolism. Prostaglandins & Other Lipid Mediators, 144, Article ID: 106363. [Google Scholar] [CrossRef] [PubMed]
[30] Watkins, P.A. and Ellis, J.M. (2012) Peroxisomal Acyl-Coa Synthetases. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1822, 1411-1420. [Google Scholar] [CrossRef] [PubMed]
[31] Sun, P., Xia, S., Lal, B., Shi, X., Yang, K.S., Watkins, P.A., et al. (2014) Lipid Metabolism Enzyme ACSVL3 Supports Glioblastoma Stem Cell Maintenance and Tumorigenicity. BMC Cancer, 14, Article No. 401. [Google Scholar] [CrossRef] [PubMed]

为你推荐